Novo Nordisk at AAPS 2026 PharmSci 360

Oct 25–28, 2026 New Orleans, LA ~4k attendees Website

Novo Nordisk brings 4 presentations to AAPS 2026 PharmSci 360 in New Orleans. Its program covers formulation technologies that manage viscosity and stability in concentrated biologics, and translational approaches to cancer therapy across new modalities.

OrganizationAAPS 2026 PharmSci 360 Attendance
Novo Nordisk
Bagsværd, Denmark
novonordisk.com
Large pharma
Danish pharmaceutical company known for diabetes and obesity medicines, including insulins and GLP-1 drugs.
Talk
Mon Oct 26
8:30am–8:40am
Welcome and Opening Remarks
USP Spotlight Stage, Exhibit Hall
with USP
Talk
Mon Oct 26
8:40am–9:00am
Fireside Chat
USP Spotlight Stage, Exhibit Hall
with USP
Session
Tue Oct 27
9:00am–11:00am
Symposium: Innovating Cancer Therapy: Translational Approaches Across New Modalities
Preclinical, Clinical, and Translational Sciences
Talk
Wed Oct 28
2:30pm–3:30pm
Hot Topic: From Viscosity to Stability: Formulation Technologies for Concentrated Biologics
208-209
Formulation and Delivery · with Harvard University, Halozyme, Stanford University

Explore the full AAPS 2026 PharmSci 360 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full AAPS 2026 PharmSci 360 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Novo Nordisk

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction